Sanofi India's board recommended a final dividend of ₹48 per share for FY25, subject to approval at the AGM.
The company communicated TDS details to shareholders, with a record date of April 22, 2026, and a deadline for TDS declarations by April 15, 2026.
TDS rates vary for residents and non-residents, with specific documentation required for lower rates or DTAA benefits.
Dividend payments will be made electronically, and physical warrants are discontinued per SEBI regulations.